Dopamine D2 and D4 receptor ligands: relation to antipsychotic action. (Q48404115)

11 February 2018

review article

1 reference

title

Dopamine D2 and D4 receptor ligands: relation to antipsychotic action. (English)

1 reference

11 February 2018

author name string

Wilson JM

series ordinal

1

1 reference

11 February 2018

Sanyal S

series ordinal

2

1 reference

11 February 2018

Van Tol HH

series ordinal

3

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 June 1998

1 reference

11 February 2018

European Journal of Pharmacology

published in

1 reference

11 February 2018

volume

351

1 reference

11 February 2018

issue

3

1 reference

11 February 2018

page(s)

273-286

1 reference

11 February 2018

Cellular distribution of the rat D4 dopamine receptor protein in the CNS using anti-receptor antisera

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Distinct binding patterns of [3H]raclopride and [3H]spiperone at dopamine D2 receptors in vivo in rat brain. Implications for pet studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Defining treatment refractoriness in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Cloning and expression of a rat D2 dopamine receptor cDNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Radioreceptor binding profile of the atypical antipsychotic olanzapine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

The case for or against heterogeneity in the etiology of schizophrenia. The genetic evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Pharmacological characterization of PD 152255, a novel dimeric benzimidazole dopamine D3 antagonist.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Limbic/mesolimbic connections and the pathogenesis of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Dopamine in schizophrenia: a review and reconceptualization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Molecular cloning and expression of the gene for a human D1 dopamine receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Characterization of the binding of [3H](+)-pentazocine to sigma recognition sites in guinea pig brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Mechanisms of action of atypical antipsychotic drugs. Implications for novel therapeutic strategies for schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Variability in D2-dopamine receptor density and affinity: a PET study with [11C]raclopride in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Phenothiazine drugs: structure-activity relationships explained by a conformation that mimics dopamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Alternative splicing directs the expression of two D2 dopamine receptor isoforms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Cloning of the cDNA and gene for a human D2 dopamine receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Multiple human D5 dopamine receptor genes: a functional receptor and two pseudogenes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Differential effects of haloperidol, clozapine, and fluperlapine on tuberoinfundibular dopamine neurons and prolactin secretion in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Multiple [3H]-nemonapride binding sites in calf brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Striatal D2 dopamine receptor characteristics in neuroleptic-naive schizophrenic patients studied with positron emission tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Linking the family of D2 receptors to neuronal circuits in human brain: insights into schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Clozapine inhibits catalepsy induced by olanzapine and loxapine, but prolongs catalepsy induced by SCH 23390 in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Positron emission tomography with (18F)methylspiperone demonstrates D2 dopamine receptor binding differences of clozapine and haloperidol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

The effects of a selective D4 dopamine receptor antagonist (L-745,870) in acutely psychotic inpatients with schizophrenia. D4 Dopamine Antagonist Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

In vivo occupancy of D2 dopamine receptors by nafadotride

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Provocative tests with psychostimulant drugs in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Selective dopamine D4 receptor antagonists reverse apomorphine-induced blockade of prepulse inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Localization of dopamine D2 receptor mRNA and D1 and D2 receptor binding in the rat brain and pituitary: an in situ hybridization-receptor autoradiographic analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

SDZ GLC 756, a novel octahydrobenzo[g]quinoline derivative exerts opposing effects on dopamine D1 and D2 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

The binding of both [3H]nemonapride and [3H]raclopride is increased in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Distribution of D2 dopamine receptor mRNA in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Dopamine receptor transcript expression in striatum and prefrontal and occipital cortex. Focal abnormalities in orbitofrontal cortex in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Localization of the mRNA for the dopamine D2 receptor in the rat brain by in situ hybridization histochemistry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

The dopamine D3 receptor antagonist, (+)-S 14297, blocks the cataleptic properties of haloperidol in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Influence of dopamine on limbic inputs to the nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Molecular cloning and expression of a D1 dopamine receptor linked to adenylyl cyclase activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Multiple D2 dopamine receptors produced by alternative RNA splicing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Localization of dopamine D4 receptors in GABAergic neurons of the primate brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Distribution of putative D4 dopamine receptors in postmortem striatum from patients with schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Messenger RNA encoding the D2 dopaminergic receptor detected by in situ hybridization histochemistry in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

CSF and serum concentrations of clozapine and its demethyl metabolite: a pilot study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

No elevated D2 dopamine receptors in neuroleptic-naive schizophrenic patients revealed by positron emission tomography and [11C]N-methylspiperone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

In Vivo D2 Dopamine Receptor Density in Psychotic and Nonpsychotic Patients With Bipolar Disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Clozapine, single photon emission tomography, and the D2 dopamine receptor blockade hypothesis of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Special antagonism of amphetamine-induced abnormal behaviour. Inhibition of stereotyped activity with increase of some normal activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Allelic Variation in the D4 Dopamine Receptor (DRD4) Gene Does Not Predict Response to Clozapine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Long-term haloperidol elevates dopamine D4 receptors by 2-fold in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Dopamine receptors and the dopamine hypothesis of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Dopamine and serotonin receptors: amino acid sequences, and clinical role in neuroleptic parkinsonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Dopamine D2-like sites in schizophrenia, but not in Alzheimer's, Huntington's, or control brains, for [3H]benzquinoline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Dopamine D4 receptors elevated in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Antipsychotic Drugs: Direct Correlation Between Clinical Potency and Presynaptic Action on Dopamine Neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Antipsychotic drug doses and neuroleptic/dopamine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Role of dopamine D2, D4 and serotonin(2A) receptors in antipsychotic and anticataleptic action.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Deriving the therapeutic concentrations for clozapine and haloperidol: the apparent dissociation constant of a neuroleptic at the dopamine D2 or D4 receptor varies with the affinity of the competing radioligand.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Dopamine D4 receptor subtypes and response to clozapine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Amphetamine psychosis: a "model" schizophrenia mediated by catecholamines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Elevation of D4 dopamine receptor mRNA in postmortem schizophrenic brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Dopamine D4 receptors and effects of guanine nucleotides on [3H]raclopride binding in postmortem caudate nucleus of subjects with schizophrenia or major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Human dopamine D1 receptor encoded by an intronless gene on chromosome 5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Sigma opiates and certain antipsychotic drugs mutually inhibit (+)-[3H] SKF 10,047 and [3H]haloperidol binding in guinea pig brain membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Regional distribution of dopamine D4 receptors in rat forebrain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Long-term effects of S(+)N-n-propylnorapomorphine compared with typical and atypical antipsychotics: differential increases of cerebrocortical D2-like and striatolimbic D4-like dopamine receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Cloning, molecular characterization, and chromosomal assignment of a gene encoding a second D1 dopamine receptor subtype: differential expression pattern in rat brain compared with the D1A receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

The case for heterogeneity in the etiology of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Striatal dopamine D2 receptor quantification and superior temporal gyrus: volume determination in 14 chronic schizophrenic subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Dopamine D2 receptor density estimates in schizophrenia: a positron emission tomography study with 11C-N-methylspiperone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Neuroendocrine responses to single oral doses of remoxipride and sulpiride in healthy female and male volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

The distribution of a dopamine D2 receptor mRNA in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Quantification of neuroreceptors in the living human brain: IV. Effect of aging and elevations of D2-like receptors in schizophrenia and bipolar illness.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Cloning and expression of human and rat D1 dopamine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

Melperone and clozapine: neuroendocrine effects of atypical neuroleptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900312-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(98)00312-4

1 reference

11 February 2018

PubMed ID

9721018

1 reference

11 February 2018